Cited by 6Cannabis and Cannabinoid ResearchCardiac Health and Mental HealthCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cardiovascular Effects of Cannabinoids

Abstract

Marijuana is now one of the most widely used substances in the United States that has been rising in prevalence given increasing legalization and recreational and medical usage. Despite its widespread use, there have been increasing concerns regarding the cardiovascular safety of marijuana. Recent studies have found a link between marijuana use and the development of cardiovascular disease. Most notably, marijuana has been found to be associated with various cardiac complications, including atherosclerosis, myocardial infarction, stroke, cardiomyopathy, arrhythmia, and arteritis. Given these growing concerns, this article seeks to examine the effects and significance of marijuana on cardiovascular health.

Overview

Integrity signals

Registry

Crossref · 10.1097/crd.0000000000000566

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 30

  1. Latif, 2020, The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use., J Clin Med, 9, 1925, 10.3390/jcm9061925 · DOI
  2. Subramaniam, 2019, The cardiovascular effects of marijuana: are the potential adverse effects worth the high?, Mo Med, 116, 146
  3. Jouanjus, 2011, Cannabis-related hospitalizations: unexpected serious events identified through hospital databases., Br J Clin Pharmacol, 71, 758, 10.1111/j.1365-2125.2010.03897.x · DOI
  4. DeFilippis, 2020, Marijuana use in patients with cardiovascular disease: JACC review topic of the week., J Am Coll Cardiol, 75, 320, 10.1016/j.jacc.2019.11.025 · DOI
  5. Rezkalla, 2019, Cardiovascular effects of marijuana., Trends Cardiovasc Med, 29, 403, 10.1016/j.tcm.2018.11.004 · DOI
  6. Pacher, 2018, Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly., Nat Rev Cardiol, 15, 151, 10.1038/nrcardio.2017.130 · DOI
  7. Thomas, 2014, Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know., Am J Cardiol, 113, 187, 10.1016/j.amjcard.2013.09.042 · DOI
  8. Singh, 2018, Cardiovascular complications of marijuana and related substances: a review., Cardiol Ther, 7, 45, 10.1007/s40119-017-0102-x · DOI
  9. Rezkalla, 2016, Cardiovascular effects of marijuana., J Cardiovasc Pharmacol Ther, 21, 452, 10.1177/1074248415627874 · DOI
  10. Ahmad, 2022, Marijuana: cardiovascular effects and legal considerations. A clinical case-based review., Br J Cardiol, 29, 11
  11. Lucas, 2018, The pharmacokinetics and the pharmacodynamics of cannabinoids., Br J Clin Pharmacol, 84, 2477, 10.1111/bcp.13710 · DOI · Paper page
  12. Abu Jad, 2022, Adverse effects of cannabinoids and tobacco consumption on the cardiovascular system: a systematic review., Cureus, 14, e29208
  13. Franz, 2016, Marijuana use and cardiovascular disease., Cardiol Rev, 24, 158, 10.1097/CRD.0000000000000103 · DOI
  14. Page, 2020, Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American heart association., Circulation, 142, e131, 10.1161/CIR.0000000000000883 · DOI
  15. Dabiri, 2021, Effects of cannabis on cardiovascular system: the good, the bad, and the many unknowns., Med Cannabis Cannabinoids, 4, 75, 10.1159/000519775 · DOI · Paper page
  16. Jones, 2002, Cardiovascular system effects of marijuana., J Clin Pharmacol, 42, 58S, 10.1002/j.1552-4604.2002.tb06004.x · DOI
  17. Vučković, 2018, Cannabinoids and pain: new insights from old molecules., Front Pharmacol, 9, 1259, 10.3389/fphar.2018.01259 · DOI
  18. Thomas, 2007, Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro., Br J Pharmacol, 150, 613, 10.1038/sj.bjp.0707133 · DOI
  19. Ramphul, 2019, Cocaine, amphetamine, and cannabis use increases the risk of acute myocardial infarction in teenagers [published correction appears in Am J Cardiol. 2019 Sep 15;124(6):994]., Am J Cardiol, 123, 354, 10.1016/j.amjcard.2018.10.019 · DOI
  20. Desai, 2017, Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States., Cureus, 9, e1816
  21. Draz, 2017, Marijuana use in acute coronary syndromes., Am J Drug Alcohol Abuse, 43, 576, 10.1080/00952990.2016.1240800 · DOI
  22. Aronow, 1974, Effect of marihuana and placebo-marihuana smoking on angina pectoris., N Engl J Med, 291, 65, 10.1056/NEJM197407112910203 · DOI
  23. Aronow, 1975, Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris., Clin Pharmacol Ther, 17, 549, 10.1002/cpt1975175549 · DOI
  24. Giorgetti, 2020, Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists., Front Psychiatry, 11, 464, 10.3389/fpsyt.2020.00464 · DOI
  25. Prakash, 1975, Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease., Clin Pharmacol Ther, 18, 90, 10.1002/cpt197518190 · DOI
  26. Kariyanna, 2019, Marijuana and cardiac arrhythmias: a scoping study., Int. J. Clin. Res. Trials, 4, 1, 10.15344/2456-8007/2019/132 · DOI
  27. Campbell, 2018, Keep off the grass: cannabis abuse and vasculitis in a teenager., Sonography, 5, 41, 10.1002/sono.12134 · DOI
  28. Noël, 2008, Cannabis arteritis., J Am Acad Dermatol, 58, S65, 10.1016/j.jaad.2007.04.024 · DOI
  29. Cottencin, 2010, Cannabis arteritis: review of the literature., J Addict Med, 4, 191, 10.1097/ADM.0b013e3181beb022 · DOI
  30. Abouk, 2018, Examining the relationship between medical cannabis laws and cardiovascular deaths in the US., Int J Drug Policy, 53, 1, 10.1016/j.drugpo.2017.11.022 · DOI

Cited by

Sorted by citations

See all 6

Metadata

Authors
Wang, A., Dey, S., Subhan, S., Patel, J., Frishman, W. H., & Aronow, W. S.
Affiliations
Westchester Medical Center (US)
Corresponding author
  • Wang, Andy
  • Dey, Subo
  • Subhan, Sarah
  • Patel, Jay
  • Frishman, William H.
Venue
Cardiology in Review
Published
2023-06-29
Volume
33
Issue
1
Pages
36-40
ISSN
  • 1061-5377 (ISSN-L)
  • 1538-4683
OpenAlex
W4382502660
Cited by
6
References
1
Citations by year
2026: 2 · 2024: 4
FWCI
0.22
Type
journal article
Language
en
Open access
closed
Locations
  • Cardiology in Review (publishedVersion)
  • PubMed (publishedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
cannabinoids, cannabis, cardiovascular disease, atherosclerosis, myocardial infarction, stroke, cardiomyopathy, cardiac arrhythmias, arteritis, cardiovascular safety
MeSH terms
Cannabinoids, Cardiovascular Diseases, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review